Skip to contentClarengateINTELLIGENCE
Companies/09427131

Ixaka Limited

Company profile

DissolvedUnited Kingdom
Register Ask analyst

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

No processed account filings

No processed accounts are available in our records.

Registered details

09427131
Status
Dissolved
Type
Unknown
Incorporated
—
Jurisdiction
—
Registered office
—

Classification

0 SIC codes

No SIC classification available.

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

0 SH01-derived rounds

No reconstructed allotment rounds.

Research and innovation

7 matched grants
MW-ATTC - Runway
Innovate UK · Centres · 2021-04-01 – 2022-03-31 · with 16 other participants
£0
awarded
University Hospitals Birmingham NHS Foundation Trustlead£237,425
Velindre University NHS Trust£170,333
Nottingham University Hospitals NHS Trust£96,264
University Hospitals Bristol NHS Foundation Trust£67,412
University Hospitals of Leicester NHS Trust£67,412
Aston University£17,919
Ixaka Limited£0
MW-ATTC - Runway
ISCF · Centres · 2021-03-31 – 2022-03-30 · with 16 other participants
£1,285,284
whole project
University Hospitals Birmingham NHS Foundation TrustleadAston UniversityBirmingham Women'S And Children'S Hospital CharityCellular Therapeutics LtdFourplus Immersive LtdGlobal Life Sciences Solutions Operations UK LtdIxaka LimitedMiltenyi Biotec LimitedNottingham University Hospitals NHS TrustOrbsen Therapeutics UK LtdThermo Electron LimitedTrakcel LimitedUniversity Hospitals Bristol NHS Foundation TrustUniversity Hospitals Of Leicester NHS TrustUniversity Of BirminghamVelindre University NHS TrustWorld Courier Management Limited
Cost-driven process redesign, automation and scale-out for commercial manufacture of REX-001 therapyLead
Innovate UK · Collaborative R&D · 2018-03-01 – 2021-03-31 · with 3 other participants
£397,508
awarded
Ixaka Limitedlead£397,508
Cost-driven process redesign, automation and scale-out for commercial manufacture of REX-001 therapyLead
ISCF · Collaborative R&D · 2018-03-01 – 2021-03-30 · with 3 other participants
£1,282,679
whole project
Cost-driven process redesign, automation and scale-out for commercial manufacture of REX-001 therapy
ISCF · Collaborative R&D · 2018-03-01 – 2021-03-30 · with 3 other participants
£1,282,679
whole project
Midlands & Wales Advanced Therapy Treatment Centre (MW-ATTC)
Innovate UK · Collaborative R&D · 2018-03-01 – 2022-03-31 · with 12 other participants
£332,414
awarded
Velindre NHS Trust£1,699,023
University Hospitals Birmingham NHS Foundation Trustlead£1,583,239
Ixaka Limited£332,414
NHS Blood and Transplant£190,938
Nottingham Uni Hospitals NHS Trust£156,772
Aston University£0
Midlands & Wales Advanced Therapy Treatment Centre (MW-ATTC)
ISCF · Collaborative R&D · 2018-03-01 – 2022-03-30 · with 12 other participants
£8,628,593
whole project
University Hospitals Birmingham NHS Foundation TrustleadAston UniversityAsymptote LimitedInstil Bio (UK) LimitedIxaka LimitedNHS Blood And TransplantNottingham Uni Hospitals NHS TrustOrbsen Therapeutics UK LtdThermo Electron LimitedTrakcel LimitedUniversity Of BirminghamVelindre NHS TrustWorld Courier Logistics (UK) Limited